Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
We first invested in Danaher, a company focused on biotechnology, life sciences and diagnostics, in the second quarter of 2016, attracted by its disciplined capital allocation, differentiated operating culture and consistent FREE cash flow generation. The business is...
— Howard Gleicher
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Danaher Corporation
Danaher Corporation is an essential designer and manufacturer of advanced instruments, diagnostic tools, and biological consumables used across pharmaceutical laboratories and medical research facilities worldwide. The investment manager...
Danaher Corporation faces challenges in its bioprocessing segment, with guidance indicating lower-than-expected growth. The company's reliance...
More institutional theses from Aristotle Value Equity Fund
Ameriprise Financial continues to generate robust growth by shifting its focus toward low-capital, fee-based wealth and asset management services. Strong equity markets...
Capital One benefits from an increased likelihood of completing its $35 billion acquisition of Discover Financial Services under a more favorable regulatory landscape. The deal would...
Lennar faced headwinds during the quarter as rising mortgage rates pressured order volumes and gross margins due to promotional incentives. Despite near-term challenges,...